Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection

American Journal of Pathology

Volumn 169, Issue 3, 2006, Pages 927-942

  Graham, Morag R ^a   Virtaneva, Kimmo ^a   Porcella, Stephen F ^a   Gardner, Donald J ^a   Long, R Daniel ^a   Welty, Diane M ^a   Barry, William T ^b   Johnson, Claire A ^a   Parkins, Larye D ^a   Wright, Fred A ^b   Musser, James M ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b IL   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MALTODEXTRIN; TRANSCRIPTOME;

ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE; STREPTOCOCCUS GROUP A;

EID: 33748867079     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060112     Document Type: Article

References (116)

1. DiNubile MJ, Lipsky BA: Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother 2004, 53:37-50
2. Musser JM, Krause RM: The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. Emerging Infections. Edited by Krause RM. New York, Academic Press, 1998, pp 185-218
3. Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13:470-511
4. Bisno AL, Brito MO, Collins CM: Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003, 3:191-200
5. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A: Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002, 35:268-276
6. Stevens DL: The flesh-eating bacterium: what's next? J Infect Dis 1999, 179:3366-3374
7. Stevens D: Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000, 51:271-288
8. Kreikemeyer B, McIver KS, Podbielski A: Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol 2003, 11:224-232
9. Hynes W: Virulence factors of the group A streptococci and genes that regulate their expression. Front Biosci 2004, 9:3399-3433
10. Virtaneva K, Porcella SF, Graham MR, Gardner DJ, Bailey JR, Parnell MJ, Musser JM: Longitudinal analysis of group Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci USA 2005, 102:9014-9019
11. Loughman JA, Caparon M: Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J Bacteriol 2006, 188:399-408
12. Handfield M, Progulske-Fox A, Hillman J: In vivo induced genes in human diseases. Periodontol 2000 2005, 38:123-134
13. Headley AJ: Necrotizing soft tissue infections: a primary care review. Am Fam Physician 2003, 68:323-328
14. Graham MR, Smoot LM, Migliaccio CAL, Virtaneva K, Sturdevant DE, Porcella SF, Federle MJ, Adams GJ, Scott JR, Musser JM: Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci USA 2002, 99:13855-13860
15. Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmelinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, De Lorenzo D, Fu YX, Musser JM: Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med 1999, 5:924-929
16. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM: Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005, 192:771-782
17. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, Bailey JR, Parnell MJ, Hoe NP, Adams GG, DeLeo FR, Musser JM: Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 2005, 102:1679-1684
18. Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, Liu M, Dou SJ, Adams GG, Musser JM: Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 2000, 68:535-542
19. Lukomski S, Montgomery CA, Rurangirwa J, Geske RS, Barrish JP, Adams GJ, Musser JM: Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 1999, 67:1779-1788
20. Graham MR, Virtaneva K, Porcella SF, Barry WT, Gowen BB, Johnson CR, Wright FA, Musser JM: Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 2005, 166:455-465
21. Aim EJ, Huang KH, Price MN, Koche RP, Keller K, Dubchak IL, Arkin AP: The MicrobesOnline web site for comparative genomics. Genome Res 2005, 15:1015-1022
22. Li C, Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001, 98:31-36
23. Yoon H, Liyanarachchi S, Wright FA, Davuluri R, Lockman JC, de la Chapelle A, Pellegata NS: Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc Natl Acad Sci USA 2002, 99:15632-15637
24. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100:9440-9445
25. Yekutieli D, Benjamini Y: Resampling based FDR controlling multiple hypotheses testing. J Stat Plan Infer 1999, 82:171-196
26. Barry WT, Nobel AB, Wright FA: Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 2005, 21:1943-1949
27. Lei B, Liu M, Chesney GL, Musser JM: Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J Infect Dis 2004, 189:79-89
28. Salim KY, Cvitkovitch DG, Chang P, Bast DJ, Handfield M, Hillman JD, de Azavedo JCS: Identification of group A Streptococcus antigenic determinants upregulated in vivo. Infect Immun 2005, 73:6026-6038
29. Teng F, Nannini EC, Murray BE: Importance of gls24 in virulence and stress response of Enterococcus faecalis and use of the Gls24 protein as a possible immunotherapy target. J Infect Dis 2005, 191:472-480
30. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, Russell HH, Turner C, Cohen J, Faulkner L, Sriskandan S: Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis 2005, 192:783-790
31. Terao Y, Kawabata S, Kunitomo E, Nakagawa I, Hamada S: Novel laminin-binding protein of Streptococcus pyogenes, Lbp, is involved in adhesion to epithelial cells. Infect Immun 2002, 70:993-997
32. Coye LH, Collins CM: Identification of SpyA, a novel ADP- ribosyltransferase of Streptococcus pyogenes. Mol Microbiol 2004, 54:89-98
33. Woodbury R, Haldenwang WG: HrcA is a negative regulator of the dnaK and groESL operons of Streptococcus pyogenes. Biochem Biophys Res Commun 2003, 302:722-727
34. Ricci S, Janulczyk R, Bjorck L: The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect Immun 2002, 70:4968-4976
35. Voyich JM, Braughton KR, Sturdevant DE, Vuong C, Kobayashi SD, Porcella SF, Otto M, Musser JM, DeLeo FR: Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J Immunol 2004, 173:1194-1201
36. Janulczyk R, Ricci S, Bjorck L: MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun 2003, 71:2656-2664
37. King KY, Horenstein JA, Caparon MG: Aerotolerance and peroxide resistance in peroxidase and perR mutants of Streptococcus pyogenes. J Bacteriol 2000, 182:5290-5299
38. Gibson CM, Mallett TC, Claiborne A, Caparon MG: Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes. J Bacteriol 2000, 182:448-455
39. Yamamoto Y, Fukui K, Koujin N, Ohya H, Kimura K, Kamio Y: Regulation of the intracellular free iron pool by Dpr provides oxygen tolerance to Streptococcus mutans. J Bacteriol 2004, 186:5997-6002
40. Ibrahim YM, Kerr AR, Silva NA, Mitchell TJ: Contribution of the ATP-dependent protease ClpCP to the autolysis and virulence of Streptococcus pneumoniae. Infect Immun 2005, 73:730-740
41. Walker M, McArthur J, McKay F, Ranson M: Is plasminogen deployed as a Streptococcus pyogenes virulence factor? Trends Microbiol 2005, 13:308-313
42. Levin JC, Wessels MR: Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 1998, 30:209-219
43. Heath A, DiRita VJ, Barg NL, Engleberg NC: A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 1999, 67:5298-5305
44. Federle MJ, McIver KS, Scott JR: A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 1999, 181:3649-3657
45. Dalton TL, Scott JR: CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J Bacteriol 2004, 186:3928-3937
46. Overweg K, Kerr A, Sluijter M, Jackson MH, Mitchell TJ, de Jong APJM, de Groot R, Hermans PWM: The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun 2000, 68:4180-4188
47. Hytonen J, Haataja S, Finne J: Streptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase. Infect Immun 2003, 71:784-793
48. Shelburne III SA, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, Musser JM: Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci USA 2005, 102:16037-16042
49. Brunskill EW, Bayles KW: Identification and molecular characterization of a putative regulatory locus that affects autolysis in Staphylococcus aureus. J Bacteriol 1996, 178:611-618
50. Titgemeyer F, Hillen W: Global control of sugar metabolism: a gram-positive solution. Antonie Van Leeuwenhoek 2002, 82:59-71
51. Seki M, Iida K, Saito M, Nakayama H, Yoshida S: Hydrogen peroxide production in Streptococcus pyogenes: involvement of lactate oxidase and coupling with aerobic utilization of lactate. J Bacteriol 2004, 186:2046-2051
52. Herwald H, Cramer H, Morgelin M, Russell W, Sollenberg U, Norrby-Teglund A, Flodgaard H, Lindbom L, Bjorck L: M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004, 116:367-379
53. Kapur V, Majesky M, Li L, Black R, Musser J: Cleavage of interleukin 1{beta} (IL-1(beta)) precursor to produce active IL-1(beta) by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 1993, 90:7676-7680
54. Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, Hamill RJ, Patti JM, Musser JM: A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 1993, 15:327-346
55. Svensson M, Scaramuzzino D, Sjobring U, Olsen A, Frank C, Bessen D: Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 2000, 38:242-253
56. Nyberg P, Rasmussen M, Bjorck L: {alpha}2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 2004, 279:52820-52823
57. Fernie-King BA, Seilly DJ, Willers C, Wurzner R, Davies A, Lachmann PJ: Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology 2001, 103:390-398
58. Frick IM, Akesson P, Rasmussen M, Schmidtchen A, Bjorck L: SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 2003, 278:16561-16566
59. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535
60. Miyoshi-Akiyama T, Takamatsu D, Koyanagi M, Zhao J, Imanishi K, Uchiyama T: Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis 2005, 192:107-116
61. Li Z, Sledjeski DD, Kreikemeyer B, Podbielski A, Boyle MD: Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol 1999, 181:6019-6027
62. Mangold M, Siller M, Roppenser B, Vlaminckx B, Penfound T, Klein R, Novak R, Novick R, Charpentier E: Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol 2004, 53:1515-1527
63. Cockerill FR, Thompson R, Musser J, Schlievert P, Talbot J, Holley K, Harmsen W, Ilstrup D, Kohner P, Kim M, Frankfort B, Manahan J, Steckelberg J, Roberson F, Wilson W: Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis 1998, 26:1448-1458
64. Bhakdi S, Tranum-Jensen J, Sziegoleit A: Mechanism of membrane damage by streptolysin-O. Infect Immun 1985, 47:52-60
65. Ruiz N, Wang B, Pentland A, Caparon M: Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci. Mol Microbiol 1998, 27:337-346
66. Limbago B, Penumalli V, Weinrick B, Scott JR: Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 2000, 68:6384-6390
67. Betschel SD, Borgia SM, Barg NL, Low DE, De Azavedo JCS: Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 1998, 66:1671-1679
68. Ginsburg I: Is streptolysin S of group A streptococci a virulence factor? APMIS 1999, 107:1051-1059
69. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, DeLeo FR: Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003, 100:10948-10953
70. Christ EA, Meals E, English BK: Streptococcal pyrogenic exotoxins A (SpeA) and C (SpeC) stimulate the production of inducible nitric oxide synthase (iNOS) protein in RAW 264.7 macrophages. Shock 1997, 8:450-453
71. Cusumano V, Fera MT, Carbone M, Anzani Ciliberti F, Bellantoni A: Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction. New Microbiologica 2000, 23:37-45
72. Rasmussen M, Müller HP, Björck L: Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J Biol Chem 1999, 274:15336-15344
73. Lottenberg R, Desjardins L, Wang H, Boyle M: Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis 1992, 166:436-440
74. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjobring U, DG: Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004, 305:1283-1286
75. Elsner A, Kreikemeyer B, Braun-Kiewnick A, Spellerberg B, Buttaro BA, Podbielski A: Involvement of Lsp, a member of the Lral lipoprotein family in Streptococcus pyogenes, in eukaryotic cell adhesion and internalization. Infect Immun 2002, 70:4859-4869
76. Ji Y, McLandsborough L, Kondagunta A, Cleary PP: C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 1996, 64:503-510
77. Hoe NP, Ireland RM, DeLeo FR, Gowen BB, Dorward DW, Voyich JM, Liu M, Burns EH, Culnan DM, Bretscher A, Musser JM: Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci USA 2002, 99:7646-7651
78. Carlsson F, Berggard K, Stalhammar-Carlemalm M, Lindahl G: Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med 2003, 198:1057-1068
79. Frick IM, Schmidtchen A, Sjobring U: Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur J Biochem 2003, 270:2303-2311
80. Carlsson F, Sandin C, Lindahl G: Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol 2005, 56:28-39
81. Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A, Musser JM: Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997, 99:2574-2580
82. Lukomski S, Burns EHJ, Wyde PR, Podbielski A, Rurangirwa J, Moore-Poveda DK, Musser JM: Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 1998, 66:771-776
83. Cleary PP, Larkin A: Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol 1979, 140:1090-1097
84. Cywes C, Wessels M: Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 2001, 414:648-652
85. Kil KS, Cunningham MW, Barnett LA: Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens. Infect Immun 1994, 62:2440-2449
86. Khil J, Im M, Heath A, Ringdahl U, Mundada L, Cary Engleberg N, Fay W: Plasminogen enhances virulence of group A streptococci by streptokinase- dependent and streptokinase-independent mechanisms. J Infect Dis 2003, 188:497-505
87. Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MDP: Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol 2004, 15:1785-1793
88. Oda T, Yamakami K, Omasu F, Suzuki S, Miura S, Sugisaki T, Yoshizawa N: Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol 2005, 16:247-254
89. Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999, 18:1096-1100
90. Gemmell C, Peterson P, Schmeling D, Kim Y, Mathews J, Wannamaker L, Quie P: Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 1981, 67:1249-1256
91. Sriskandan S, McKee A, Hall L, Cohen J: Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J Antimicrob Chemother 1997, 40:275-277
92. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak M, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002, 8:1398-1404
93. Kazmi SU, Kansal R, Aziz RK, Hooshdaran M, Norrby-Teglund A, Low DE, Halim AB, Kotb M: Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group A streptococcal isolates in vivo. Infect Immun 2001, 69:4988-4995
94. Kansal RG, Aziz RK, Kotb M: Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions. J Infect Dis 2005, 191:2121-2129
95. Reid SD, Green NM, Sylva GL, Voyich JM, Stenseth ET, DeLeo FR, Palzkill T, Low DE, Hill HR, Musser JM: Postgenomic analysis of four novel antigens of group A Streptococcus: growth phase-dependent gene transcription and human serologic response. J Bacteriol 2002, 184:6316-6324
96. Degnan BA, Fontaine MC, Doebereiner AH, Lee JJ, Mastroeni P, Dougan G, Goodacre JA, Kehoe MA: Characterization of an isogenic mutant of Streptococcus pyogenes Manfrede lacking the ability to make streptococcal acid glycoprotein. Infect Immun 2000, 68:2441-2448
97. Degnan BA, Palmer JM, Robson T, Jones CED, Fischer M, Glanville M, Mellor GD, Diamond AG, Kehoe MA, Goodacre JA: Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun 1998, 66:3050-3058
98. Gruening P, Fulde M, Valentin-Weigand P, Goethe R: Structure, regulation, and putative function of the arginine deiminase system of Streptococcus suis. J Bacteriol 2006, 188:361-369
99. Ravins M, Jaffe J, Hanski E, Shetzigovski I, Natanson-Yaron S, Moses AE: Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. J Infect Dis 2000, 182:1702-1711
100. Raeder R, Harokopakis E, Hollingshead S, Boyle MD: Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun 2000, 68:744-751
101. Engleberg CN, Heath A, Miller A, Rivera C, DiRita VJ: Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 2001, 183:1043-1054
102. 2+. Proc Natl Acad Sci USA 2003, 100:4227-4232
103. Voyich JM, Sturdevant DE, Braughton KR, Kobayashi SD, Lei B, Virtaneva K, Dorward DW, Musser JM, DeLeo FR: Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 2003, 100:1996-2001
104. Caparon MG, Geist RT, Perez-Casal J, Scott JR: Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol 1992, 174:5693-5701
105. VanHeyningen T, Fogg G, Yates D, Hanski E, Caparon M: Adherence and fibronectin binding are environmentally regulated in the group A streptococci. Mol Microbiol 1993, 9:1213-1222
106. Smoot LM, Smoot JC, Graham MR, Somerville GA, Sturdevant DE, Migliaccio CA, Sylva GL, Musser JM: Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc Natl Acad Sci USA 2001, 98:10416-10421
107. Kreikemeyer B, Boyle MD, Buttaro BA, Heinemann M, Podbielski A: Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol 2001, 39:392-406
108. Kristian SA, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A, Gallo RL, Nizet V: D-Alanylation of teichoic acids promotes group A Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol 2005, 187:6719-6725
109. Deutscher J, Herro R, Bourand A, Mijakovic I, Poncet S: P-Ser-HPr-a link between carbon metabolism and the virulence of some pathogenic bacteria. Biochim Biophys Acta 2005, 1754:118-125
110. Boyce JD, Wilkie I, Harper M, Paustian ML, Kapur V, Adler B: Genomic scale analysis of Pasteurella multocida gene expression during growth within the natural chicken host. Infect Immun 2002, 70:6871-6879
111. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, Calderwood SB, Schoolnik GK, Camilli A: Host-induced epidemic spread of the cholera bacterium. Nature 2002, 417:642-645
112. Xu Q, Dziejman M, Mekalanos JJ: Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci USA 2003, 100:1286-1291
113. Stintzi A, Marlow D, Palyada K, Naikare H, Panciera R, Whitworth L, Clarke C: Use of genome-wide expression profiling and mutagenesis to study the intestinal lifestyle of Campylobacter jejuni. Infect Immun 2005, 73:1797-1810
114. Conway T, Schoolnik GK: Microarray expression profiling: capturing a genome-wide portrait of the transcriptome. Mol Microbiol 2003, 47:879-889
115. Shelburne S, Musser J: Virulence gene expression in vivo. Curr Opin Microbiol 2004, 7:283-289
116. Boyce J, Cullen P, Adler B: Genomic-scale analysis of bacterial gene and protein expression in the host. Emerg Infect Dis 2004, 10:1357-1362